Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 4, pp. 1167-1176
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 16, 2011
- Revision received November 6, 2011
- Accepted December 15, 2011
- Published first January 6, 2012.
Article Versions
- Previous version (January 6, 2012 - 06:54).
- Previous version (February 3, 2012 - 11:05).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Natasha Rekhtman1,
- Paul K. Paik2,
- Maria E. Arcila1,
- Laura J. Tafe1,
- Geoffrey R. Oxnard2,
- Andre L. Moreira1,
- William D. Travis1,
- Maureen F. Zakowski1,
- Mark G. Kris2, and
- Marc Ladanyi1,3
- Authors' Affiliations: 1Department of Pathology, 2Thoracic Oncology Service, Department of Medicine, and 3Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York
- Corresponding Author:
Natasha Rekhtman, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C583, New York, NY 10065. Phone: 212-639-5905; Fax: 212-639-6318; E-mail: rekhtman{at}mskcc.org
February 2012
Volume 18, Issue 4
Volume 18, Issue 4
Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
Jump to section
Advertisement